ANAVEX-22-1068

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameANAVEX-22-1068
Drug Alias NameANAVEX-22-1068
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor agonists
TargetsSigma-2 receptor
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnavex Life Sciences Corp
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A